|
Gallego P, Roldán V, Marin F, Gálvez J, Valdés M, Vicente V, Lip GY. SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation. Am J Med. 2014 Nov;127(11):1083-8. doi: 10.1016/j.amjmed.2014.05.023. PubMed PMID: 24858062.
AÑO: 2014; IF: 5.003
|
24858062
|
Jover E, Rodríguez JM, Bernal A, Arroyo AB, Iniesta JA, Guiú IS, Martínez C, Vicente V, Lozano ML, Rivera J. High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests. Blood Coagul Fibrinolysis. 2014 Sep;25(6):604-11. doi: 10.1097/MBC.0000000000000118. PubMed PMID: 24717421.
AÑO: 2014; IF: 1.203
|
|
Alvarez-Larrán A, Martínez-Avilés L, Hernández-Boluda JC, Ferrer-Marín F, Antelo ML, Burgaleta C, Mata MI, Xicoy B, Martínez-Trillos A, Gómez-Casares MT, Durán MA, Marcote B, Ancochea A, Senín A, Angona A, Gómez M, Vicente V, Cervantes F, Bellosillo B, Besses C. Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea. Ann Hematol. 2014 Dec;93(12):2037-43. doi: 10.1007/s00277-014-2152-7. PubMed PMID: 24981691.
AÑO: 2014; IF: 2.634
|
|
Roldán V, Arroyo AB, Salloum-Asfar S, Manzano-Fernández S, García-Barberá N, Marín F, Vicente V, González-Conejero R, Martínez C. Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation. Thromb Haemost. 2014 Oct;112(4):781-8. doi: 10.1160/TH14-01-0092. PubMed PMID: 25008481.
AÑO: 2014; IF: 4.984
|
|
Aguila S, Martínez-Martínez I, Dichiara G, Gutiérrez-Gallego R, Navarro-Fernández J, Vicente V, Corral J. Increased N-glycosylation efficiency by generation of an aromatic sequon on N135 of antithrombin. PLoS One. 2014 Dec 8;9(12):e114454. doi: 10.1371/journal.pone.0114454. Erratum in: PLoS One. 2015;10(3):e0122177. PubMed PMID: 25485983; PubMed Central PMCID: PMC4259341.
AÑO: 2014; IF: 3.234
|